Thumbnail Image

Thesis

Browse

2008 - 200912010 - 20201
Reset filters
Author: CHAITANYA, YALAVARTHI ×
Reset filters

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    ThesisItemOpen Access
    CLINICO-DIAGNOSTIC AND THERAPEUTIC STUDIES ON RENAL DISEASE IN DOGS
    (SRI VENKATESWARA VETERINARY UNIVERSITY TIRUPATI - 517 502. (A.P.) INDIA, 2020-12) CHAITANYA, YALAVARTHI; LAKSHMI RANI, N (MAJOR); VAIKUNTA RAO, V; RAVI KUMAR, P; SREENU, MAKKENA
    During the study period of two years, the occurrence of renal diseases in dogs accounted up to 3.40 per cent in. Among the affected dogs, 18.24 per cent suffered with acute kidney injury, whereas 81.76 per cent were of chronic kidney disease. Kidney diseases were more prevalent in male dogs, aged above 8 years and the occurrence was more in Pomeranian (30.82%). In the affected dogs, the clinical presentation varied from asymptomatic to typical clinical signs. Detailed haemato- biochemical examination and imaging studies performed in 128 dogs revealed that, 25 dogs were affected with AKI and 103 dogs had CKD. The dogs with CKD were further categorized into four stages based on SDMA values as stage I, II, III and IV. The SDMA values in the affected dogs ranged from 14 to 152 μg/dL. Sub staging of CKD dogs was done based on UPC and Blood pressure. Significant difference (P0.05) was noticed in mean values of PI and RI in acute kidney injury and chronic kidney disease stage I and II with the healthy control while the same in chronic kidney disease stage III and IV varied significantly (P0.05) was noticed in mean values of LA/Ao and M mode echocardiographic findings in dogs with acute kidney injury which varied significantly (P<0.05) in chronic kidney disease. Therapy was initiated in dogs with kidney diseases by using herbal antioxidant, diuretic, phosphate binders, antibiotics, diuretic, ACE inhibitors, nutritional therapy, haematinics, fluid therapy along with specific treatment and were monitored for a period of 3 months. The survival percentage of dogs with acute kidney injury (Group I) was 84.00% per cent (21/25). The survival percentage was 100.00 per cent in Group IIa (17/17) and IIb (15/15) i.e., chronic kidney disease stage I and stage II, where as it was 80.00 per cent (20/25) in CKD stage III (Group IIc) and 56.00 per cent (26/46) in chronic kidney disease stage IV (Group IId). Significant difference (p<0.05) was recorded in the SDMA/creatinine ratio(9.20±0.18 in survivors vs 12.07 ± 0.42 in non survivors, BUN ( 82.53±1.84 mg/dL vs 148.62±12.82mg/dL), product of calcium and phosphorus(58.22±2.02 vs 89.32±1.92), sodium to potassium ratio (39.42±1.02 vs 48.93±1.32) , UPC (1.92±0.22 vs 3.86±0.52 ) and resistive index (0.62±0.56 vs 0.74±0.24) between survivors and non survivors
  • Thumbnail Image
    ThesisItemOpen Access
    CLINICO-THERAPEUTIC STUDIES ON DYSPEPSIA WITH PARTICULAR REFERENCE TO HEPATIC INVOLVEMENT IN CANINE
    (SRI VENKATESWARA VETERINARY UNIVERSITY TIRUPATI - 517 502. (A.P.) INDIA, 2008-12) CHAITANYA, YALAVARTHI; TIRUMALA RAO, D.S(MAJOR); HAMZA, P.A; GIREESH KUMAR, V
    ABSTRACT: The Present investigation was conducted to study clinical, haemato-biochemical, ultrasonographic findings, and therapeutic efficacy of certain drugs in dogs with dyspepsia with particular reference to hepatic involvement in canine. During the period of 8 months of present study, 30 dogs with hepatic involvement were selected basing on serum biochemical findings. Dyspepsia (100%) was the most common complaint followed by vomiting (80%), lethargy (57%), ascites (53%), diarrhea (33%), anemia (23%), melena (20%), jaundice (13%), fever(13%) and neurological signs(7%) . Elevated levels of serum ALT,serum ALP, serum GGT, total bilirubin and hypoproteinemia, hypoalbuminaemia and hypoglycemia were most important biochemical alterations in dogs with dyspepsia and hepatic involvement. After therapy a significant (p< 0.05) improvement was noticed in Hb, serum ALP, serum GGT, total protein and glucose levels in group-I. Similarly in group II, a significant (p< 0.05) improvement was seen in TEC, TLC, Hb, ALT, ALP, GGT, total protein, albumin, glucose levels. In group III, a significant (p< 0.05) improvement was seen in TEC, TLC, Hb, DLC, ALT, ALP, GGT, total protein, albumin, glucose levels, total bilirubin levels were significant in group III(p< 0.05). In the present study 10 cases were randomly selected for ultrasonography on the basis of available clinical, laboratory and morphological records. The relative efficacy of certain drugs was evaluated. The group I dogs received a combination of orally administered silymarin and iron supplement along with fluids (DNS) parenterally. The group II dogs received a combination of liver extract and B-complex vitamins and iron supplement along with fluids (DNS) parenterally. The therapeutic efficacy of this group was significant (p < 0.05) on day 7. This therapeutic regimen was useful in treating mild cases where infectious agent was not involved. The group III dogs received a combination of liver extract and B-complex vitamins, prednisolone and antibiotics along with fluids (DNS) parenterally. The therapeutic efficacy of this group was significant (p < 0.05) on day 7. This therapeutic regimen was useful in treating severe cases where infectious agent was involved and also in cirrhotic cases. Based on the findings of the present investigation it could be concluded that dyspepsia has involvement with sub optimal functional status of liver. It was concluded from this study that hepatic involvement and its complications can be cured successfully in dogs by conservative therapy if diagnosed at an early stage of the ailment.